Yüklüyor......
Donepezil for the Treatment of Language Deficits in Adults With Down Syndrome: A Preliminary 24-Week Open Trial
At present, there is no proven pharmacologic treatment for cognitive or language impairments in Down syndrome (DS). Cholinergic deficits have been documented in DS and linked to cognitive deficits. This study is a 24-week open-label clinical trial of donepezil hydrochloride for the treatment of lang...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2003
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3129998/ https://ncbi.nlm.nih.gov/pubmed/12494428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajmg.a.10074 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|